✦ LIBER ✦

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy

✍ Scribed by Elena M. Massarotti; Nancy Y. Liu; James Mier; Michael B. Atkins

Book ID: 115684306
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 764 KB
Volume: 92
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(92)90789-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose inhalation interleukin-2 thera

High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma

✍ Alexander H. Enk; Dorothee Nashan; Albert Rübben; Jürgen Knop 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## BACKGROUND. The lungs are a frequent site of metastasis in patients with melanoma, and this may cause respiratory problems in the terminal phase of the illness. Inhalation interleukin (IL)-2 therapy to the lung has been piloted and appears to be well tolerated. ## METHODS. Twenty-seven patien

Increased numbers of circulating haemato

Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients

✍ M. R. Schaafsma; W. E. Fibre; D. Van Der Harst; N. Duinkerken; A. Brand; S. Osan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Should High-Dose Interleukin-2 Still Be

Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?

✍ Dillman, Robert O.; Barth, Neil M.; VanderMolen, Louis A.; Mahdavi, Khosrow; McC 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 263 KB

Treatment of chronic inflammatory demyel

Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up

✍ Börü, Ülkü Türk; Erdoğan, Hülya; Alp, Recep; Taşdemir, Mustafa; Yıldırım, Serhan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Serum globulins as marker of immune rest

Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia

✍ Doru T. Alexandrescu; Peter H. Wiernik 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 324 KB

Comparison of acute toxicity and mortali

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

✍ Laura M. Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 252 KB